Weight Loss Clinical Trials in Los Angeles, CA

17 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance	Phase 4	AbbVie	<1 mi
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue	Phase 2/3	Pfizer	<1 mi
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC)	—	Cedars-Sinai Medical Center	<1 mi
BrainWeighve App Feasibility Study	N/A	University of California, Los Angeles	<1 mi
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients	N/A	Nitinotes Surgical Ltd.	<1 mi
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant	N/A	Jonsson Comprehensive Cancer Center	<1 mi
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients	N/A	University of California, Los Angeles	<1 mi
Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Metastatic Colorectal Cancer Undergoing Chemotherapy	Phase 2	Endevica Bio	<1 mi
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy	Phase 2	Stephen Freedland	<1 mi
Benefits of Endoscopic Bariatric Procedures	N/A	Cedars-Sinai Medical Center	<1 mi
Restoring Facial Volume After GLP-1 Weight Loss With Radiesse	Phase 4	Kalpna Kay Durairaj, MD, FACS	9 mi
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia	Phase 1	AVEO Pharmaceuticals, Inc.	9 mi
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus	Phase 2	Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics	18 mi
A Study of Weekly Oral Ecnoglutide (VRB-101) in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities	Phase 2	Verdiva Bio Dev Limited	20 mi
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide	Phase 3	Novo Nordisk A/S	20 mi
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass	N/A	Boston Scientific Corporation	36 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.